期刊名称：RHEUMATOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Rheumatology publishes original clinical, laboratory, and therapeutic research, as well as papers on rehabilitation.
In addition to many full length original research papers, each issue includes editorials, regular scientific reviews, clinical grand rounds, preliminary and brief papers, viewpoints, book reviews, and a lively correspondence section.
CATEGORY: Rheumatology
Rank: 4/22 (2001)
Rank: 2/23 (2000)
Rank: 3/20 (1999) |
|
Instructions to Authors
Note: Rheumatology requires online submission of all articles
Rheumatology publishes papers and correspondence concerning all aspects of rheumatology. Original articles on clinical, laboratory and therapeutic research are especially welcome; in general these should not exceed seven printed pages of the Journal, c. 3500 or 4000 words or fewer (excluding the abstract and references) depending on the number of figures and tables. Concise Reports of scientific work are also published but should contain less than 2000 words and no more than two figures or tables. Reviews are welcome. Correspondence is encouraged and letters are published rapidly. Case Reports should be submitted in the form of Letters to the Editor or where appropriate in the form of a Clinical Grand Round, and priority is given to previously undescribed conditions or complications and those with a valuable message. A letter to the Editor should be less than 800 words with no more than ten references and no more that one figure or table.
Rheumatology requires submission through the Rheumatology Manuscript Central website at Manuscript Central website.
PLEASE NOTE: ALL AUTHORS ARE NOW REQUIRED TO PROVIDE:
- AN AUTHORSHIP STATEMENT SIGNED BY ALL AUTHORS.
- DECLARATION OF ANY CONFLICT OF INTERESTS TO BE PUBLISHED IN THE JOURNAL. IF NO CONFLICT OF INTERESTS ARE DECLARED THIS WILL BE PUBLISHED IN THE ARTICLE.
- KEY MESSAGES ABOUT THE ARTICLE, WHICH WILL BE PUBLISHED IN A BOX IN THE ARTICLE.
PAGE CHARGES WILL BE APPLIED TO ALL PAPERS IN EXCESS OF 7 PRINTED PAGES.
The presentation of original work should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals obtainable from the Editor, British Medical Journal, BMA House, Tavistock Square, London WC1H 3JR, UK. These requirements are also given in the Annals of Internal Medicine 1997;126:36?7. Randomized controlled trials should be presented in a manner and format consistent with the CONSORT statement (J Am Med Assoc 1996;276:637?).
AUTHORSHIP
All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically, and must have read and approved the final version. All authors will be required to submit a statement confirming that they meet these authorship criteria.
ORIGINALITY
An article is reviewed for publication on the understanding that the work it represents has not be submitted for publication elsewhere. If the work or an abstract of it has been previously published, for instance, in another language, then this fact should be made clear in the covering letter. Authors must declare, and submit copies of, any manuscripts in preparation or submitted elsewhere that are closely related to the manuscript to be considered. Duplicate or redundant publication is considered a serious form of misconduct and may be reported to employing institutions and funding bodies, or lead to a public notice in the Journal, and rejection of new manuscripts from the author.
CONFLICT OF INTEREST
All authors must make a formal statement at the time of submission indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Such conflicts might include, but are not limited to, shareholding in or receipt of a grant or consultancy fee from a company whose product features in the submitted manuscript or which manufactures a competing product. All authors must submit a statement of Conflict of Interest to be published at the end of their article. If no Conflict of Interest is declared this will be stated in the article.
ETHICS
All manuscripts in which experiments on patients or healthy volunteers, patients' case histories or use of genetic material are reported should (1) contain a statement that the subjects' written consent was obtained according to the Declaration of Helsinki (Br Med J 1996;31:1448?), and (2) the design of the work has been approved by local ethical committees or that it conforms to standards currently applied in the country of origin; the name of the authorizing body should be stated in the paper. The Editorial Board reserves the right to reject papers where the ethical aspects are, in the Board's opinion, open to doubt.
ON-LINE SUBMISSION
All submissions must be made online through the website: Manuscript Central website. For further instructions on the online submissions process please click here or visit the website. In the event that this causes difficulty please contact the editorial office: editorial@rheumatology.org.uk
MANUSCRIPT PREPARATION
Each of the following sections should begin on a new page and all pages should be numbered serially.
- Title page containing the title of the article, the authors' names and affiliations, the name, address, telephone and fax numbers and e-mail address of the author responsible for correspondence, a short title of not more than 45 characters for each page (running head).
- A Structured Abstract of not more than 150?50 words, using the headings Objectives, Methods, Results and Conclusions. Up to 10 key words that reflect the content of the article and will facilitate it being found through Internet searches.
- Main text.
- Acknowledgements.
- References.
- Tables, each table should be typed on a separate sheet with an appropriate legend and footnotes explaining any abbreviations.
- Legends for illustrations.
- A Conflict of Interest statement, as described above, to be published in the Journal. If no Conflict of Interest is declared the following statement will be published in the journal 'No Conflict of Interest has been declared by the author(s)'.
- Two or three Key Messages that readers should take from the paper, describing, for example, the significance or relevance of the paper's conclusions. The Key Messages should not be more than 30 words in total (i.e. 10?5 words each). For Case Reports only one Key Message (not more than 10 words) should be provided.
REFERENCES
References in the text should be given as numbers in brackets, placed in line with the text and in order of appearance. They should be listed in numerical order at the end of the paper. All authors should be included in a reference when there are six or less but only the first three followed by et al. when there are seven or more. Authors' names should be followed by the title of article, abbreviated name of the Journal (as per PubMed abbreviations), year, volume and first and last page numbers. References to books should state the author, followed by chapter title, editors' names, book title, place of publication, publisher, year, and appropriate page numbers.
Examples:
- Hirayama T, Danks L, Sabokbar A, Athanasou N A. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 2002; 41:1232?.
- Mitchell SC, Waring RH. S-Oxygenase III human harmacogenetics. In: Damani LA, ed. Sulphur-containing drugs and related organic compounds, Vol. 2B. New York: Ellis Horwood, 1989:101-19.
Unpublished communications should be cited in the text in parentheses.
An Original Article should not have more than 50 references.
A Concise Report should not have more than 20 references.
A Letter should not have more than 10 references.
ILLUSTRATIONS
High-resolution figures are required for publication, but low-resolution figures are preferred for online review. (Please see Manuscript Central website for acceptable formats.) Therefore it is advisable to generate figures at a high resolution initially and save a second, low-resolution, version for the submission/review process. HARD COPY SHOULD ALSO BE AVAILABLE, ACCORDING TO THE FOLLOWING INSTRUCTIONS:
Figures will be sized to fit the width of a single or a double column of text, i.e. 85 or 172 mm wide.
Any lettering should be in proportion with the overall dimensions of the drawing. Parts of figures should be labelled, preferably with upper case A, B, C etc.
Photographs. These should be of sufficiently high quality with respect to detail, contrast and fineness of grain to withstand the inevitable loss of contrast and detail inherent in the printing process. Please indicate the original magnification by a bar (e.g. 1 cm) on the photograph. When several prints of the same figure are provided, please indicate which print should be used for reproduction in the Journal.
Colour plates. Colour illustrations are accepted, but the authors will be required to pay the cost of the reproduction. Alternatively colour can be published online only, as Supplementary data, with a black and white version being published in the print version of the journal.
Line drawings. No additional artwork, redrawing or typesetting will be done. Faint or fine-grained stippling or shading or continuous-tone shading will be lost or may appear black on reproduction. Please use a coarse stippling or hatching.
Figure legends. Define all symbols and abbreviations used in the figure. Common abbreviations or those which have been defined in the text should not be redefined in the figure legend.
Any previously published material should be accompanied by the permission of the author and copyright holder for its reproduction.
MEASUREMENTS
Measurements of length, height, weight and volume should be reported in metric units (metre, kilogram, litre) or their decimal multiples. Temperatures should be given in degrees Celsius and blood pressure in mmHg. All other measurements including laboratory measurements should be reported in the metric system in terms of the International System of Units (SI).
Abbreviations for SI units and statistical terms are those in Baron DN (ed.): Units Symbols and Abbreviations: A Guide for Biological and Medical Editors and Authors, 4th ed. London: Royal Society of Medicine.
MATERIALS
When quoting specific materials or proprietary drugs, authors must state in parentheses the name and address of the manufacturer. Generic names should be used if possible.
STATISTICS
Statistical methods must be detailed and should conform with the statistical guidelines published in Br J Rheumatol 1992;31:2.
ABBREVIATIONS
Abbreviations should be unambiguous; if they do not appear in the list given below, their meaning should be clearly explained when they are first introduced.
AIDS: acquired immune deficiency syndrome
ANA: antinuclear antibodies
ANCA: antineutrophil cytoplasmic antibodies
ACR: American College of Rheumatology
ARA: American Rheumatism Association
AS: ankylosing spondylitis
BMD: bone mineral density
BMI: body mass index
CI: confidence interval
CPPD: calcium pyrophosphate dihydrate
CRP: C-reactive protein
CT: computed tomograph
DIP: distal interphalangeal joint
DISH: diffuse idiopathic skeletal hypeostosis
DMARD: disease-modifying anti-rheumatic drug
ECG: electrocardiogram
ELISA: enzyme-linked immunosorbent assay
ESR: erythrocyte sedimentation rate
HIV: human immunodeficiency virus
IL: interleukin
JCA: juvenile chronic arthritis
MCP: metacarpophalangeal
MHC: major histocompatibility complex
MRI: magnetic resonance imaging
NSAID: non-steroidal anti-inflammatory drug
OA: osteoarthritis
PI: proximal interphalangeal
PsA: psoriatic arthritis
RA: rheumatoid arthritis
RF: rheumatoid factor
S.D.: standard deviation
S.E.M.: standard error of the mean
SF: synovial fluid
SM: synovial membrane
SLE: systemic lupus erythematosus
SS: Sj鰃ren's syndrome
TNF: tumour necrosis factor
SUPPLEMENTARY DATA
Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that are additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures (including colour, which is published online-only at no charge to the authors). All text and figures must be provided in suitable electronic formats (instructions for the preparation of Supplementary Data are available here. All material to be considered as Supplementary Data must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication. Please indicate clearly the material intended as Supplementary Data upon submission. Also ensure that the Supplementary Data are referred to in the main manuscript where necessary.
PAGE CHARGES
There is a page limit of 7 printed pages per article. For all pages over this limit the authors will be charged ?5 (~US$150) per additional page.
PROOFS
Authors are sent PDF page proofs by e-mail. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned by fax to Oxford University Press [+44 (0)1865 353798]. The Publisher reserves the right to charge authors for the cost of changes made to the text or the figures at proof stage when such changes are extensive. No charge will be made for corrections of errors made during the editorial process or by the printer.
COPYRIGHT
It is a condition of publication in Rheumatology that authors grant an exclusive licence to the Journal, published by Oxford University Press on behalf of the British Society for Rheumatology. Licence to Publish forms are available on the website and must be printed off, completed, signed and mailed to the Editorial office at the time of submission. For any manuscripts that are not accepted, the Licence to Publish form will be destroyed. [It is a condition of publication that the ORIGINAL signed Licence to Publish form be returned to the publisher.] This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning the Licence, Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Oxford University Press is notified in writing and in advance.
OFFPRINTS
The Publisher will supply free electronic access to each article. Printed offprints may be ordered at an extra cost at proof stage.
MATERIAL DISCLAIMER
The opinions expressed in Rheumatology are those of the authors and contributors, and do not necessarily reflect those of the British Society for Rheumatology, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated.
DRUG DISCLAIMER
The mention of trade names, commercial products or organizations, and the inclusion of advertisements in the Journal does not imply endorsement by the British Society for Rheumatology, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in the Journal. The ultimate responsibility for the use and dosage of drugs mentioned in the Journal and in the interpretation of published material lies with the medical practitioner, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in the Journal. Please inform the editors of any errors.
Editorial Board
Editor:
R A Watts
Editorial Manager:
S J Cubie
Editorial Assistant:
S A Woudberg
Rheumatology
41 Eagle Street
London, WC1R 4AR
Tel +44 (0)20 7841 5190
Fax +44 (0)20 7242 1841
E-mail: editorial@rheumatology.org.uk
Associate Editors:
T Cawston, UK
H Gaston, UK
I McInnes, UK
U M黮ler-Ladner, Germany
L Nelson, USA
L Wedderburn, UK
Editorial Board:
M Bayliss, UK
C Black, UK
F Brennan, UK
H Capell, UK
F Cavalcanti, Brazil
A Cope, UK
M E Cutolo,Italy
J-M Dayer, Switzerland
C Deighton, UK
C Denton, UK
P Emery, UK
O FitzGerald, Ireland
C Gordon, UK
D Haskard, UK
A Hassell, UK
N Hurst, UK
D Isenberg, UK
J Kirwan, UK
L Klareskog, Sweden
T Kvien, Norway
O Lesnyak, Russia
N. Miyasaka, Japan
G Mody, South Africa
R Moots, UK
E Morand, Australia
K Nishioka, Japan
T O'Neill, UK
E Pascual, Spain
C Pitzalis, UK
P van Riel, Netherlands
M Salmi, Finland
T Saxne, Sweden
J Sieper, Germany
A Silman, UK
D Walker, UK
P Wordsworth, UK
Publishers: Sending Books for Review
| 
刊名字顺( Alphabetical List of Journals):
返回页首 